Effects of an academic detailing service on benzodiazepine prescribing patterns in primary care
Lacroix M, Abdelmalek F, Everett K, Salach L, Bevan L, Burton V, Ivers NM, Tadrous M. PLoS One. 2023; 18(7):e0289147. Epub 2023 Jul 27.
Publications
Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: a population-based time series analysis
Ledlie S, Tadrous M, McCormack D, Campbell T, Leece P, Kleinman RA, Kolla G, Besharah J, Smoke A, Sproule B, Gomes T. Int J Drug Policy. 2923; 118:104119. Epub 2023 Jul 8.
The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive study
Campbell TJ, Men S, Shearer D, Ebejer T, Joosse M, Quercia J, Sanders J, Tadrous M, Antoniou T, Gomes T; on behalf of the Ontario Drug Policy Research Network Citizens’ Panel. Can J Public Health. 2023; Jun 16 [Epub ahead of print].
Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study
Antoniou T, Wang T, Pajer K, Gardner W, Lunsky Y, Penner M, Tadrous M, Mamdani M, Juurlink DN, Gomes T. Front Psychiatry. 2023; 14:1172559. Epub 2023 May 12.
Sex-based differences in severe outcomes, including cardiovascular hospitalization, in adults with COVID-19 in Ontario, Canada
Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Dzavík V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA. JACC Adv. 2023; May 10 [Epub ahead of print].
Up-to-date on cancer screening among Ontario patients seen by walk-in clinic physicians: a retrospective cohort study
Lofters A, Salahub C, Austin PC, Bai L, Berthelot S, Bhatia RS, Desveaux L, Ivers NM, Kiran T, Maclure M, Martin D, McBrien KA, McCracken R, Paterson JM, Rahman B, Shuldiner J, Tadrous M, Thakkar N, Lapointe-Shaw L. Prev Med. 2023; 172:107537. Epub 2023 May 6.
Virtual care use prior to emergency department admissions during a stable COVID-19 period in Ontario, Canada
Stamenova V, Chu C, Borgundvaag E, Fleury C, Brual J, Bhattacharyya O, Tadrous M. PLoS One. 2023; 18(4):e0277065. Epub 2023 Apr 28.
Walk-in clinic patient characteristics and utilization patterns in Ontario, Canada: a cross-sectional study
Lapointe-Shaw L, Kiran T, Salahub C, Austin PC, Berthelot S, Desveaux L, Lofters A, Maclure M, Martin D, McBrien KA, McCracken RK, Rahman B, Schultz SE, Shuldiner J, Tadrous M, Bird C, Paterson JM, Bhatia RS, A Thakkar NA, Na Y, Ivers NM. CMAJ Open. 2023; 11(2):E345-56. Epub 2023 Apr 25.
Impact of a publicly-funded pharmacare program on prescription stimulant use among children and youth: a population-based observational natural experiment
Antoniou T, McCormack D, Kitchen S, Pajer K, Gardner W, Lunsky Y, Penner M, Tadrous M, Mamdani M, Juurlink DN, Gomes T. Can J Psychiatry. 2023; Apr 5 [Epub ahead of print].
A comparison of family physician and dermatologist topical corticosteroid prescriptions: a population-based cross-sectional study
Bowie AC, Tadrous M, Thiruchelvam D, Ivers NM, Mohan T, Tu K, Jaakkimainen L, Drucker AM. J Am Acad Dermatol. 2023; 88(6):1291-9. Epub 2023 Mar 11.